Literature DB >> 8025354

A paediatric Crohn's disease activity index (PCDAI). Is it useful? Study Group on Crohn's Disease in Children and Adolescents.

H K Harms1, R Blomer, R M Bertele-Harms, D H Shmerling, M König, A Spaeth.   

Abstract

Since 1976, various activity indices for Crohn's disease have been developed but none has been suitable for use in the paediatric age group. Therefore, the German-Swiss Study Group on Crohn's Disease in Children and Adolescents decided to develop their own paediatric Crohn's disease activity index (PCDAI) by multiple regression analysis of prospectively collected data. The result was a simple index consisting of two clinical (appetite, number of stools/week) and four laboratory variables (erythrocyte sedimentation rate, serum iron and alpha 2-globulin concentrations and bands as percentage of white blood cells). Applying the index to patients who were followed-up, it could be demonstrated that the changes in PCDAI inversely reflected the changes in weight and that the surgical removal of the inflamed parts of the gut reduced the disease activity index to levels comparable to those obtained in patients after successful, exclusively conservative, treatment. Low disease activity was maintained for at least three years.

Entities:  

Mesh:

Year:  1994        PMID: 8025354     DOI: 10.1111/j.1651-2227.1994.tb13224.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  2 in total

1.  Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease.

Authors:  Eva Szigethy; Ada O Youk; Joseph Gonzalez-Heydrich; Simona I Bujoreanu; John Weisz; Diane Fairclough; Peter Ducharme; Neil Jones; Francis Lotrich; David Keljo; Arvind Srinath; Athos Bousvaros; David Kupfer; David R DeMaso
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

2.  Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission.

Authors:  Yao Lv; Yue Lou; Gan Yang; Youyou Luo; Jingan Lou; Qi Cheng; Jindan Yu; Youhong Fang; Hong Zhao; Kerong Peng; Jie Chen
Journal:  Gastroenterol Res Pract       Date:  2022-09-02       Impact factor: 1.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.